API 0.74% $1.35 australian pharmaceutical industries limited

2012 half year result, page-5

  1. 2,105 Posts.
    lightbulb Created with Sketch. 41
    Solid half year result on which to build.

    Last 10 years have been pretty tough and disappointing and were the result of a combination some pretty poor leadership, poor financial management and some things beyond their control.

    I think we now have a pretty solid base on which to build and take advantage the opportunities flowing from the ageing population.

    Definitely a long term buy to put away and collect some solid dividends in the future.
 
watchlist Created with Sketch. Add API (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.